ENSC
Ensysce Biosciences, Inc. (ENSC)
Last Price$3.9(0.5%)
Market Cap$4,609.2K

ENSC Q4’24 Earnings

MetricEstimatesActualsSurprise
Revenue$245.0K$0.0
MISS by 100.0%
EPS($2.74)($2.90)
MISS by 6.0%

ENSC Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$1,000.0K$2,000.0K$3,000.0KApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$862.4K$827.6K$250.6K$1,200.8K$603.1K$279.4K$789.6K$435.4K$305.7K$0.0
Value Sense
Actual Revenue
Forecast Revenue

ENSC Earnings History

Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$0.0$0.0$0.0$0.0$0.0$0.0$0.0$0.0$0.0$0.0$862.4K$1,824.7K$827.6K$416.5K$250.6K$444.5K$1,200.8K$1,635.3K$603.1K$207.5K$279.4K$1,433.5K$789.6K$490.5K$435.4K$515.0K$305.7K$181.8K$0.0$0.0
Revenue estimateN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$1,200.0K$800.0K$1,200.0K$1,000.0K$1,000.0K$1,540.0K$950.0K$760.0K$593.3K$395.0K$400.0K$300.0K$3,400.0K$245.0K
Revenue surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.1%104.4%49.7%79.3%72.1%6.9%16.9%35.5%26.6%30.4%23.6%39.4%100.0%100.0%
EPS actual($0.19)($1.43)$0.07$0.07$0.10$0.12$0.13$0.14$0.08($0.11)($0.05)($10.72)$23.90$3.26($14.40)($13.99)($169.83)($100.00)$25.65($62.35)($84.13)($8.46)($1.73)($0.98)($0.87)($1.55)($0.55)($0.22)$0.07($2.90)
EPS estimateN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A($8.52)$1.08($1.92)($2.04)($1.92)($28.88)($76.15)($27.80)($15.85)($13.05)($13.50)($5.85)$1.05($2.74)
EPS surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%1,893.3%9,359.3%1,435.9%2,956.4%4,281.8%70.7%97.7%96.5%94.5%88.1%95.9%96.2%93.6%6.0%

ENSC Price Change after Earnings

Crunching data... Almost there!

ENSC Recent Quarter Financial Statements Overview

Income statement
Balance sheet
Cash Flow statement
Operating expenses
$3,576.5K (2.6%) YoY
Net income
$3,564.4K 1.7% YoY
0.0% margin
Other: $4,868.1K
R&D
$3,802.6K 70.3% YoY
0.0% of revenue
SG&A
$1,077.5K (25.1%) YoY
0.0% of revenue

Competing with ENSC Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$4,609.2K
$487.5K
($3.60)
(100.0%)
87.1%
undefinedN/A
undefinedN/A
0.0%
5.0%
Beats: 7
Misses: 3
N/A
(99.9%)
$132.4B
$11.0B
($2.06)
15.7%
(5.6%)
undefinedN/A
undefinedN/A
(1.7%)
20.2%
Beats:
Misses:
8.6%
(962.4%)
$72.4B
$14.2B
$40.88
10.3%
(21.6%)
undefinedN/A
undefinedN/A
(10.2%)
9.3%
Beats: 8
Misses: 2
2.4%
3.1%
$36.9B
$3,154.8M
$11.71
219.9%
N/A
undefinedN/A
undefinedN/A
(45.6%)
(83.5%)
Beats: 7
Misses: 3
76.3%
(132.2%)
$32.2B
$2,248.2M
($2.17)
34.9%
(40.9%)
undefinedN/A
undefinedN/A
(0.4%)
45.9%
Beats: 8
Misses: 2
28.6%
(26.5%)
$23.9B
€2,751.1M
(€3.84)
(19.5%)
(100.0%)
undefinedN/A
undefinedN/A
(79.9%)
0.0%
Beats: 5
Misses: 5
(28.0%)
(182.9%)
$14.9B
$2,263.9M
$2.31
(0.3%)
(58.6%)
undefinedN/A
undefinedN/A
22.5%
132.0%
Beats: 5
Misses: 5
35.4%
144.6%
$14.6B
$0.0
($0.31)
(100.0%)
62.6%
undefinedN/A
undefinedN/A
0.0%
(8.4%)
Beats: 6
Misses: 4
N/A
11.4%
$14.4B
$2,877.4M
$26.45
19.7%
45.9%
undefinedN/A
undefinedN/A
(0.9%)
(3.0%)
Beats: 7
Misses: 3
9.1%
6.8%
$13.7B
$2,850.5M
$2.25
15.6%
490.9%
undefinedN/A
undefinedN/A
(0.9%)
7.4%
Beats: 8
Misses: 2
10.0%
48.9%

FAQ

1. When was Ensysce Biosciences, Inc.'s last earnings date?

Ensysce Biosciences, Inc.'s last earnings date was Sep'24 (Q4 2024).

2. What is Ensysce Biosciences, Inc.'s EPS, and was there a surprise?

3. What is Ensysce Biosciences, Inc.'s revenue, and was there a surprise?

4. What is Ensysce Biosciences, Inc.'s next quarter EPS estimate?

Ensysce Biosciences, Inc.'s next quarter EPS estimate is ($2.74), with an expected (83.8%) YoY growth.